NCT04212039View on ClinicalTrials.gov

Pericapsular Nerve Group (PENG) Block for Congenital Hip Dislocation Surgery

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

July 1, 2022

Study Completion Date

September 1, 2022

Conditions
Congenital Hip Dysplasia
Interventions
DRUG

Saline Solution

0.5 ml/kg saline

DRUG

Bupivacaine

0.5 ml/kg %0.25 bupivacaine

Trial Locations (1)

25100

Ataturk University, Erzurum

All Listed Sponsors
lead

Ataturk University

OTHER

NCT04212039 - Pericapsular Nerve Group (PENG) Block for Congenital Hip Dislocation Surgery | Biotech Hunter | Biotech Hunter